Skip to Content

IDEXX Laboratories Inc IDXX

Morningstar Rating
$571.28 −5.59 (0.97%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Idexx's Upcoming New InVue Platform Launch Should Support Growth Into the Long Term

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a narrow moat. It is well-positioned to benefit from two key trends. First, pet ownership continues to grow, offering a secular tailwind since the late 1980s. Moreover, pet owners have demonstrated greater willingness to spend more on their animals, having more than tripled spending on pet products and services since 1994.

Price vs Fair Value

IDXX is trading within a range we consider fairly valued.
Price
$570.88
Fair Value
$865.00
Uncertainty
Medium
1-Star Price
$417.00
5-Star Price
$297.00
Economic Moat
Nrzgdb
Capital Allocation
Mkbdhncb

Bulls Say, Bears Say

Bulls

Unlike human healthcare, pet health services and products require cash payments—thereby bypassing the reimbursement issues and pricing pressure associated with third-party payers.

Bears

International sales account for a substantial chunk of Idexx's total revenue; as the U.S. dollar strengthens, Idexx would feel the pain on its top and bottom lines.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IDXX is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$576.87
Day Range
$565.01580.18
52-Week Range
$372.50583.39
Bid/Ask
$560.00 / $571.00
Market Cap
$47.47 Bil
Volume/Avg
323,489 / 485,016

Key Statistics

Price/Earnings (Normalized)
56.30
Price/Sales
13.10
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.15%

Company Profile

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Growth
Total Number of Employees
11,000

Competitors

Valuation

Metric
IDXX
ZTS
Price/Earnings (Normalized)
56.3035.31
Price/Book Value
32.0517.23
Price/Sales
13.1010.16
Price/Cash Flow
48.9730.31
Price/Earnings
IDXX
ZTS

Financial Strength

Metric
IDXX
ZTS
Quick Ratio
1.031.77
Current Ratio
1.573.36
Interest Coverage
26.3912.85
Quick Ratio
IDXX
ZTS

Profitability

Metric
IDXX
ZTS
Return on Assets (Normalized)
30.25%17.35%
Return on Equity (Normalized)
84.34%52.06%
Return on Invested Capital (Normalized)
40.19%21.87%
Return on Assets
IDXX
ZTS
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncPckmk$221.8 Bil
DHR
Danaher CorpZdbpkyg$189.5 Bil
IQV
IQVIA Holdings IncSsfzcmy$45.8 Bil
A
Agilent Technologies IncXvqj$41.9 Bil
MTD
Mettler-Toledo International IncDbfbkd$27.6 Bil
ICLR
Icon PLCDfrljz$27.3 Bil
ILMN
Illumina IncNdzhtnd$21.9 Bil
WAT
Waters CorpPpkcc$20.5 Bil
LH
Laboratory Corp of America HoldingsKlrqx$18.4 Bil

Sponsor Center